Loading…
Gastrointestinal Tolerance and Protein Absorption Markers with a New Peptide Enteral Formula Compared to a Standard Intact Protein Enteral Formula in Critically Ill Patients
The aim of this exploratory study was to investigate gastrointestinal tolerance and protein absorption markers with a new enteral peptide formula (PF) compared to an isocaloric enteral intact protein standard formula (SF) containing the same amount of protein in ICU patients. Patients admitted to a...
Saved in:
Published in: | Nutrients 2021-07, Vol.13 (7), p.2362 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c446t-482e19fb8202077d4fb0bdc016f406575eeff6701e3be0e6aab421ec77ecad7f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c446t-482e19fb8202077d4fb0bdc016f406575eeff6701e3be0e6aab421ec77ecad7f3 |
container_end_page | |
container_issue | 7 |
container_start_page | 2362 |
container_title | Nutrients |
container_volume | 13 |
creator | de Brito-Ashurst, Ione Klebach, Marianne Tsompanaki, Eleni Kaul, Sundeep van Horssen, Peter Hofman, Zandrie |
description | The aim of this exploratory study was to investigate gastrointestinal tolerance and protein absorption markers with a new enteral peptide formula (PF) compared to an isocaloric enteral intact protein standard formula (SF) containing the same amount of protein in ICU patients. Patients admitted to a cardio-thoracic intensive care unit expected to receive tube feeding for ≥5 days were randomized to receive either PF (1.5 kcal/mL) or SF in a double-blind manner for ≤14 days. Twenty-six patients were randomized (13 SF and 13 PF) and 23 (12 SF and 11 PF) completed at least 5 days of product administration. There were no statistically significant differences between the feeds during the first 5 days of intervention for diarrhea (SF:3 (23%); PF:5 (39%), p = 0.388), vomiting (SF:1 (8%); PF:2 (15%), p = 0.549), constipation (SF:7 (54%), PF:3 (23%), p = 0.115), and high gastric residual volume (>500 mL: SF:1 (8%); PF: 2 (15%), p = 0.535). There were no differences in plasma amino acids or urinary markers of protein absorption and metabolism. In conclusion, no major differences were found in tolerability and protein absorption markers between the standard intact protein formula and the peptide formula. |
doi_str_mv | 10.3390/nu13072362 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_daaf520476ec4b40a846f5493681b569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A765644600</galeid><doaj_id>oai_doaj_org_article_daaf520476ec4b40a846f5493681b569</doaj_id><sourcerecordid>A765644600</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446t-482e19fb8202077d4fb0bdc016f406575eeff6701e3be0e6aab421ec77ecad7f3</originalsourceid><addsrcrecordid>eNptksFuEzEQhlcIRKvSC09giQtCSvGuvfbmghRFbYlUIBLlbM16x6mDYwfb26oPxTvikKolFfbBo5l_Pns8U1Vva3rG2JR-9GPNqGyYaF5Ux02xJkJw9vIf-6g6TWlNd0tSKdjr6ohxJutONsfV70tIOQbrM6ZsPThyHRxG8BoJ-IEsY8hoPZn1KcRttsGTLxB_YkzkzuYbAuQr3pElltCA5LxgYmFchLgZHZB52Gwh4kByKMrvuRAhDmThM-j8yH6eVVzzaLPV4Nw9WThHlpAt-pzeVK8MuISnD-dJ9ePi_Hr-eXL17XIxn11NNOciT3jXYD01fdfQ8gty4Kan_aBpLQynopUtojFC0hpZjxQFQM-bGrWUqGGQhp1Uiz13CLBW22g3EO9VAKv-OkJcKYjlgQ7VAGDahnIpUPOeU-i4MC2fMtHVfSumhfVpz9qO_QYHXeooxR5ADyPe3qhVuFUdo51oWQG8fwDE8GssbVIbmzQ6Bx7DmFTTCkpF6W1dpO-eSddhjKWrO1XLpZSCyyfVCkoB1ptQ7tU7qJpJ0Yryh5QW1dl_VGUPuLE6eDS2-A8SPuwTdAwpRTSPNdZU7WZVPc0q-wPDftuY</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2554777647</pqid></control><display><type>article</type><title>Gastrointestinal Tolerance and Protein Absorption Markers with a New Peptide Enteral Formula Compared to a Standard Intact Protein Enteral Formula in Critically Ill Patients</title><source>PubMed (Medline)</source><source>ProQuest - Publicly Available Content Database</source><creator>de Brito-Ashurst, Ione ; Klebach, Marianne ; Tsompanaki, Eleni ; Kaul, Sundeep ; van Horssen, Peter ; Hofman, Zandrie</creator><creatorcontrib>de Brito-Ashurst, Ione ; Klebach, Marianne ; Tsompanaki, Eleni ; Kaul, Sundeep ; van Horssen, Peter ; Hofman, Zandrie</creatorcontrib><description>The aim of this exploratory study was to investigate gastrointestinal tolerance and protein absorption markers with a new enteral peptide formula (PF) compared to an isocaloric enteral intact protein standard formula (SF) containing the same amount of protein in ICU patients. Patients admitted to a cardio-thoracic intensive care unit expected to receive tube feeding for ≥5 days were randomized to receive either PF (1.5 kcal/mL) or SF in a double-blind manner for ≤14 days. Twenty-six patients were randomized (13 SF and 13 PF) and 23 (12 SF and 11 PF) completed at least 5 days of product administration. There were no statistically significant differences between the feeds during the first 5 days of intervention for diarrhea (SF:3 (23%); PF:5 (39%), p = 0.388), vomiting (SF:1 (8%); PF:2 (15%), p = 0.549), constipation (SF:7 (54%), PF:3 (23%), p = 0.115), and high gastric residual volume (>500 mL: SF:1 (8%); PF: 2 (15%), p = 0.535). There were no differences in plasma amino acids or urinary markers of protein absorption and metabolism. In conclusion, no major differences were found in tolerability and protein absorption markers between the standard intact protein formula and the peptide formula.</description><identifier>ISSN: 2072-6643</identifier><identifier>EISSN: 2072-6643</identifier><identifier>DOI: 10.3390/nu13072362</identifier><identifier>PMID: 34371872</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Absorption ; Chromatography ; Constipation ; Creatinine ; Data collection ; Defecation ; Diarrhea ; gastrointestinal tolerance ; Hospital patients ; hydrolyzed protein ; ICU ; Markers ; Metabolism ; Nitrogen ; Nutrition ; nutritional guidelines ; Parenteral nutrition ; Patients ; Peptides ; Phenols ; Physiological aspects ; polymeric formula ; protein absorption ; Protein turnover ; Proteins ; Statistical analysis ; Thorax ; Vomiting</subject><ispartof>Nutrients, 2021-07, Vol.13 (7), p.2362</ispartof><rights>COPYRIGHT 2021 MDPI AG</rights><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446t-482e19fb8202077d4fb0bdc016f406575eeff6701e3be0e6aab421ec77ecad7f3</citedby><cites>FETCH-LOGICAL-c446t-482e19fb8202077d4fb0bdc016f406575eeff6701e3be0e6aab421ec77ecad7f3</cites><orcidid>0000-0002-4035-3471 ; 0000-0003-4694-9126</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2554777647/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2554777647?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids></links><search><creatorcontrib>de Brito-Ashurst, Ione</creatorcontrib><creatorcontrib>Klebach, Marianne</creatorcontrib><creatorcontrib>Tsompanaki, Eleni</creatorcontrib><creatorcontrib>Kaul, Sundeep</creatorcontrib><creatorcontrib>van Horssen, Peter</creatorcontrib><creatorcontrib>Hofman, Zandrie</creatorcontrib><title>Gastrointestinal Tolerance and Protein Absorption Markers with a New Peptide Enteral Formula Compared to a Standard Intact Protein Enteral Formula in Critically Ill Patients</title><title>Nutrients</title><description>The aim of this exploratory study was to investigate gastrointestinal tolerance and protein absorption markers with a new enteral peptide formula (PF) compared to an isocaloric enteral intact protein standard formula (SF) containing the same amount of protein in ICU patients. Patients admitted to a cardio-thoracic intensive care unit expected to receive tube feeding for ≥5 days were randomized to receive either PF (1.5 kcal/mL) or SF in a double-blind manner for ≤14 days. Twenty-six patients were randomized (13 SF and 13 PF) and 23 (12 SF and 11 PF) completed at least 5 days of product administration. There were no statistically significant differences between the feeds during the first 5 days of intervention for diarrhea (SF:3 (23%); PF:5 (39%), p = 0.388), vomiting (SF:1 (8%); PF:2 (15%), p = 0.549), constipation (SF:7 (54%), PF:3 (23%), p = 0.115), and high gastric residual volume (>500 mL: SF:1 (8%); PF: 2 (15%), p = 0.535). There were no differences in plasma amino acids or urinary markers of protein absorption and metabolism. In conclusion, no major differences were found in tolerability and protein absorption markers between the standard intact protein formula and the peptide formula.</description><subject>Absorption</subject><subject>Chromatography</subject><subject>Constipation</subject><subject>Creatinine</subject><subject>Data collection</subject><subject>Defecation</subject><subject>Diarrhea</subject><subject>gastrointestinal tolerance</subject><subject>Hospital patients</subject><subject>hydrolyzed protein</subject><subject>ICU</subject><subject>Markers</subject><subject>Metabolism</subject><subject>Nitrogen</subject><subject>Nutrition</subject><subject>nutritional guidelines</subject><subject>Parenteral nutrition</subject><subject>Patients</subject><subject>Peptides</subject><subject>Phenols</subject><subject>Physiological aspects</subject><subject>polymeric formula</subject><subject>protein absorption</subject><subject>Protein turnover</subject><subject>Proteins</subject><subject>Statistical analysis</subject><subject>Thorax</subject><subject>Vomiting</subject><issn>2072-6643</issn><issn>2072-6643</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptksFuEzEQhlcIRKvSC09giQtCSvGuvfbmghRFbYlUIBLlbM16x6mDYwfb26oPxTvikKolFfbBo5l_Pns8U1Vva3rG2JR-9GPNqGyYaF5Ux02xJkJw9vIf-6g6TWlNd0tSKdjr6ohxJutONsfV70tIOQbrM6ZsPThyHRxG8BoJ-IEsY8hoPZn1KcRttsGTLxB_YkzkzuYbAuQr3pElltCA5LxgYmFchLgZHZB52Gwh4kByKMrvuRAhDmThM-j8yH6eVVzzaLPV4Nw9WThHlpAt-pzeVK8MuISnD-dJ9ePi_Hr-eXL17XIxn11NNOciT3jXYD01fdfQ8gty4Kan_aBpLQynopUtojFC0hpZjxQFQM-bGrWUqGGQhp1Uiz13CLBW22g3EO9VAKv-OkJcKYjlgQ7VAGDahnIpUPOeU-i4MC2fMtHVfSumhfVpz9qO_QYHXeooxR5ADyPe3qhVuFUdo51oWQG8fwDE8GssbVIbmzQ6Bx7DmFTTCkpF6W1dpO-eSddhjKWrO1XLpZSCyyfVCkoB1ptQ7tU7qJpJ0Yryh5QW1dl_VGUPuLE6eDS2-A8SPuwTdAwpRTSPNdZU7WZVPc0q-wPDftuY</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>de Brito-Ashurst, Ione</creator><creator>Klebach, Marianne</creator><creator>Tsompanaki, Eleni</creator><creator>Kaul, Sundeep</creator><creator>van Horssen, Peter</creator><creator>Hofman, Zandrie</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4035-3471</orcidid><orcidid>https://orcid.org/0000-0003-4694-9126</orcidid></search><sort><creationdate>20210701</creationdate><title>Gastrointestinal Tolerance and Protein Absorption Markers with a New Peptide Enteral Formula Compared to a Standard Intact Protein Enteral Formula in Critically Ill Patients</title><author>de Brito-Ashurst, Ione ; Klebach, Marianne ; Tsompanaki, Eleni ; Kaul, Sundeep ; van Horssen, Peter ; Hofman, Zandrie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446t-482e19fb8202077d4fb0bdc016f406575eeff6701e3be0e6aab421ec77ecad7f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Absorption</topic><topic>Chromatography</topic><topic>Constipation</topic><topic>Creatinine</topic><topic>Data collection</topic><topic>Defecation</topic><topic>Diarrhea</topic><topic>gastrointestinal tolerance</topic><topic>Hospital patients</topic><topic>hydrolyzed protein</topic><topic>ICU</topic><topic>Markers</topic><topic>Metabolism</topic><topic>Nitrogen</topic><topic>Nutrition</topic><topic>nutritional guidelines</topic><topic>Parenteral nutrition</topic><topic>Patients</topic><topic>Peptides</topic><topic>Phenols</topic><topic>Physiological aspects</topic><topic>polymeric formula</topic><topic>protein absorption</topic><topic>Protein turnover</topic><topic>Proteins</topic><topic>Statistical analysis</topic><topic>Thorax</topic><topic>Vomiting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Brito-Ashurst, Ione</creatorcontrib><creatorcontrib>Klebach, Marianne</creatorcontrib><creatorcontrib>Tsompanaki, Eleni</creatorcontrib><creatorcontrib>Kaul, Sundeep</creatorcontrib><creatorcontrib>van Horssen, Peter</creatorcontrib><creatorcontrib>Hofman, Zandrie</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Physical Education Index</collection><collection>ProQuest - Health & Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals(OpenAccess)</collection><jtitle>Nutrients</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Brito-Ashurst, Ione</au><au>Klebach, Marianne</au><au>Tsompanaki, Eleni</au><au>Kaul, Sundeep</au><au>van Horssen, Peter</au><au>Hofman, Zandrie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gastrointestinal Tolerance and Protein Absorption Markers with a New Peptide Enteral Formula Compared to a Standard Intact Protein Enteral Formula in Critically Ill Patients</atitle><jtitle>Nutrients</jtitle><date>2021-07-01</date><risdate>2021</risdate><volume>13</volume><issue>7</issue><spage>2362</spage><pages>2362-</pages><issn>2072-6643</issn><eissn>2072-6643</eissn><abstract>The aim of this exploratory study was to investigate gastrointestinal tolerance and protein absorption markers with a new enteral peptide formula (PF) compared to an isocaloric enteral intact protein standard formula (SF) containing the same amount of protein in ICU patients. Patients admitted to a cardio-thoracic intensive care unit expected to receive tube feeding for ≥5 days were randomized to receive either PF (1.5 kcal/mL) or SF in a double-blind manner for ≤14 days. Twenty-six patients were randomized (13 SF and 13 PF) and 23 (12 SF and 11 PF) completed at least 5 days of product administration. There were no statistically significant differences between the feeds during the first 5 days of intervention for diarrhea (SF:3 (23%); PF:5 (39%), p = 0.388), vomiting (SF:1 (8%); PF:2 (15%), p = 0.549), constipation (SF:7 (54%), PF:3 (23%), p = 0.115), and high gastric residual volume (>500 mL: SF:1 (8%); PF: 2 (15%), p = 0.535). There were no differences in plasma amino acids or urinary markers of protein absorption and metabolism. In conclusion, no major differences were found in tolerability and protein absorption markers between the standard intact protein formula and the peptide formula.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>34371872</pmid><doi>10.3390/nu13072362</doi><orcidid>https://orcid.org/0000-0002-4035-3471</orcidid><orcidid>https://orcid.org/0000-0003-4694-9126</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6643 |
ispartof | Nutrients, 2021-07, Vol.13 (7), p.2362 |
issn | 2072-6643 2072-6643 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_daaf520476ec4b40a846f5493681b569 |
source | PubMed (Medline); ProQuest - Publicly Available Content Database |
subjects | Absorption Chromatography Constipation Creatinine Data collection Defecation Diarrhea gastrointestinal tolerance Hospital patients hydrolyzed protein ICU Markers Metabolism Nitrogen Nutrition nutritional guidelines Parenteral nutrition Patients Peptides Phenols Physiological aspects polymeric formula protein absorption Protein turnover Proteins Statistical analysis Thorax Vomiting |
title | Gastrointestinal Tolerance and Protein Absorption Markers with a New Peptide Enteral Formula Compared to a Standard Intact Protein Enteral Formula in Critically Ill Patients |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A01%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gastrointestinal%20Tolerance%20and%20Protein%20Absorption%20Markers%20with%20a%20New%20Peptide%20Enteral%20Formula%20Compared%20to%20a%20Standard%20Intact%20Protein%20Enteral%20Formula%20in%20Critically%20Ill%20Patients&rft.jtitle=Nutrients&rft.au=de%20Brito-Ashurst,%20Ione&rft.date=2021-07-01&rft.volume=13&rft.issue=7&rft.spage=2362&rft.pages=2362-&rft.issn=2072-6643&rft.eissn=2072-6643&rft_id=info:doi/10.3390/nu13072362&rft_dat=%3Cgale_doaj_%3EA765644600%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c446t-482e19fb8202077d4fb0bdc016f406575eeff6701e3be0e6aab421ec77ecad7f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2554777647&rft_id=info:pmid/34371872&rft_galeid=A765644600&rfr_iscdi=true |